The potential role of ventricular compressive therapy

Area of Science:

• Cardiology
• Biomedical Engineering
• Pathophysiology

Background:

• Early infarct expansion contributes to ventricular dilatation, contractile dysfunction, and poor prognosis in heart failure.
• Ventricular remodeling leading to congestive heart failure (CHF) is hypothesized to initiate with infarct expansion, increasing myocardial stress.
• Increased stress in border zone myocardium triggers cytokine and reactive oxygen species (ROS) production, leading to myocyte apoptosis, extracellular matrix (ECM) disruption, and fibrosis.

Purpose of the Study:

• To evaluate the unclear value of ventricular compressive therapy in established CHF using the Acorn Cardiac Support Device (CSD).
• To assess the potential of early ventricular compressive therapy (ventricular restraint) as a prophylactic measure against infarct expansion and subsequent remodeling.

Main Methods:

• Review of early clinical and laboratory studies on Acorn CSD safety and efficacy in established CHF.
• Experimental demonstration of early ventricular restraint's effect on cardiac remodeling.

Main Results:

• Acorn CSD placement is safe with standard surgical techniques; constrictive physiology is rare.
• Clinical benefit from Acorn CSD in established CHF has not been dramatic in limited patient cases.
• Experimental studies show early ventricular restraint dramatically ameliorates remodeling.

Conclusions:

• A definitive assessment of Acorn CSD in established CHF requires a clinical trial comparing it with optimal medical management.
• Early ventricular compressive therapy (prophylactic prevention of infarct expansion) is a promising strategy demonstrated experimentally.
• Further research is needed to determine the optimal timing for early ventricular compressive therapy interventions.